City

Columbus (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

National Cancer Institute (NCI) (1)

Collaborator

Intervention

cetuximab (1)

laboratory biomarker analysis (1)

lenalidomide (1)

Study Documents

Intervention Type

biological (1)

drug (1)

other (1)

Funder Type

NIH (1)

Study Type

Interventional (1)

stage ivc laryngeal squamous cell carcinoma ajcc v7

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recurrent Colon Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma Trial

Completed

Recurrent Colon Carcinoma
+41 more

Cetuximab
+2 more

Columbus, Ohio

Ohio State University Comprehensive Cancer Center

Mar 12, 2020